Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ulcerative colitis: an epithelial disease?

P R Gibson1

  • 1University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Victoria, Australia.

Bailliere'S Clinical Gastroenterology
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutritional profile of rodent diets impacts experimental reproducibility in microbiome preclinical research.

Scientific reports·2020
Same author

Gluten-free and low-FODMAP sourdoughs for patients with coeliac disease and irritable bowel syndrome: A clinical perspective.

International journal of food microbiology·2018
Same author

Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders.

Alimentary pharmacology & therapeutics·2018
Same author

Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.

Alimentary pharmacology & therapeutics·2018
Same author

Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).

Alimentary pharmacology & therapeutics·2018
Same author

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.

Alimentary pharmacology & therapeutics·2018
Same journal

Index.

Bailliere's clinical gastroenterology·2020
Same journal

Home enteral and parenteral nutrition in children.

Bailliere's clinical gastroenterology·1999
Same journal

Nutritional support in malnourished paediatric patients.

Bailliere's clinical gastroenterology·1999
Same journal

Cholestasis and end-stage liver disease.

Bailliere's clinical gastroenterology·1999
Same journal

Cystic fibrosis: nutritional consequences and management.

Bailliere's clinical gastroenterology·1999
Same journal

Pancreatic diseases (excluding cystic fibrosis).

Bailliere's clinical gastroenterology·1999
See all related articles

Epithelial abnormalities in ulcerative colitis may precede and drive inflammation. Targeting these defects could offer new therapeutic strategies for this chronic condition.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Immunology

Background:

  • Ulcerative colitis (UC) is characterized by colonic epithelial abnormalities.
  • These abnormalities may exist independently of active mucosal inflammation.
  • Current understanding suggests a central role for epithelial dysfunction in UC pathogenesis.

Purpose of the Study:

  • To propose a model where epithelial barrier defects initiate and perpetuate colonic inflammation in UC.
  • To explore potential molecular mechanisms underlying epithelial dysfunction in UC.
  • To highlight the therapeutic potential of targeting colonic epithelium in UC management.

Main Methods:

  • Review and synthesis of existing evidence on colonic epithelium in UC.
  • Development of a pathogenetic model focusing on epithelial barrier function.

Related Experiment Videos

  • Discussion of candidate molecular hypotheses for epithelial abnormalities.

    • Main Results:

    • Epithelial abnormalities are proposed as the primary defect in UC.
    • Impaired epithelial barrier function allows luminal factors to trigger inflammation.
    • The interaction of epithelium with various factors critically impairs barrier function.

    Conclusions:

    • Epithelial abnormalities are central to UC pathogenesis, potentially preceding inflammation.
    • A novel therapeutic approach focusing on epithelial repair and barrier restoration is proposed.
    • Targeting the colonic epithelium may lead to new management strategies for ulcerative colitis.